Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.

Keith Willett

Professor Keith Willett has been recognised in The Queen's Birthday Honours List, awarded the highest honour of knighthood. Prof Willett is the National Director for Emergency Planning and Incident Response to NHS England and NHS Improvement and is the Professor of Orthopaedic Trauma Surgery at the University of Oxford. 40 years in the NHS and a consultant surgeon, he has extensive experience of trauma and emergency care, healthcare management and driving service transformation.

In 2018 he was appointed the Strategic Commander to deliver the preparation of the NHS to leave the EU. Then in January 2020 as Strategic Incident Director he also took on the responsibility for leading the NHS response to the coronavirus pandemic across England.

Prof Willett said: "I am very honoured to be recognised. I am also acutely aware of the very many good people in the NHS family who in recent times have given so much, and some, everything.'

In 1994 Prof Willett co-founded the 24-hour consultant-resident Oxford Trauma Service. In 2003 he founded the Kadoorie Centre for Critical Care Research and Education in Oxford focusing on the treatment of critically ill and injured patients. 2009 saw him appointed as the first National Clinical Director for Trauma Care to the Department of Health and he was charged with developing and implementing government policy to improve the care of older people with hip fractures and to establish Regional Trauma Networks and Major Trauma Centres. By 2012 both re-organisations and care pathways were successfully in place and are credited with marked improvement in patient care and survival.

Professor Andrew Carr, Head of Department at NDORMS said: “Congratulations to Keith for receiving this highest honour it is a well deserved recognition of his outstanding contributions over many years that has resulted in both improvement in the quality of life and also the  saving of lives of patients in the NHS."

 

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.